Asymptomatic carrier state, acute respiratory disease, and pneumonia due to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2): Facts and myths.
Identifieur interne : 000479 ( PubMed/Corpus ); précédent : 000478; suivant : 000480Asymptomatic carrier state, acute respiratory disease, and pneumonia due to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2): Facts and myths.
Auteurs : Chih-Cheng Lai ; Yen Hung Liu ; Cheng-Yi Wang ; Ya-Hui Wang ; Shun-Chung Hsueh ; Muh-Yen Yen ; Wen-Chien Ko ; Po-Ren HsuehSource :
- Journal of microbiology, immunology, and infection = Wei mian yu gan ran za zhi [ 1995-9133 ] ; 2020.
Abstract
Since the emergence of coronavirus disease 2019 (COVID-19) (formerly known as the 2019 novel coronavirus [2019-nCoV]) in Wuhan, China in December 2019, which is caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), more than 75,000 cases have been reported in 32 countries/regions, resulting in more than 2000 deaths worldwide. Despite the fact that most COVID-19 cases and mortalities were reported in China, the WHO has declared this outbreak as the sixth public health emergency of international concern. The COVID-19 can present as an asymptomatic carrier state, acute respiratory disease, and pneumonia. Adults represent the population with the highest infection rate; however, neonates, children, and elderly patients can also be infected by SARS-CoV-2. In addition, nosocomial infection of hospitalized patients and healthcare workers, and viral transmission from asymptomatic carriers are possible. The most common finding on chest imaging among patients with pneumonia was ground-glass opacity with bilateral involvement. Severe cases are more likely to be older patients with underlying comorbidities compared to mild cases. Indeed, age and disease severity may be correlated with the outcomes of COVID-19. To date, effective treatment is lacking; however, clinical trials investigating the efficacy of several agents, including remdesivir and chloroquine, are underway in China. Currently, effective infection control intervention is the only way to prevent the spread of SARS-CoV-2.
DOI: 10.1016/j.jmii.2020.02.012
PubMed: 32173241
Links to Exploration step
pubmed:32173241Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Asymptomatic carrier state, acute respiratory disease, and pneumonia due to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2): Facts and myths.</title>
<author><name sortKey="Lai, Chih Cheng" sort="Lai, Chih Cheng" uniqKey="Lai C" first="Chih-Cheng" last="Lai">Chih-Cheng Lai</name>
<affiliation><nlm:affiliation>Department of Internal Medicine, Kaohsiung Veterans General Hospital, Tainan Branch, Tainan, Taiwan.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Liu, Yen Hung" sort="Liu, Yen Hung" uniqKey="Liu Y" first="Yen Hung" last="Liu">Yen Hung Liu</name>
<affiliation><nlm:affiliation>Department of Internal Medicine, Cardinal Tien Hospital and School of Medicine, College of Medicine, Fu Jen Catholic University, New Taipei City, Taiwan.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Wang, Cheng Yi" sort="Wang, Cheng Yi" uniqKey="Wang C" first="Cheng-Yi" last="Wang">Cheng-Yi Wang</name>
<affiliation><nlm:affiliation>Department of Internal Medicine, Cardinal Tien Hospital and School of Medicine, College of Medicine, Fu Jen Catholic University, New Taipei City, Taiwan.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Wang, Ya Hui" sort="Wang, Ya Hui" uniqKey="Wang Y" first="Ya-Hui" last="Wang">Ya-Hui Wang</name>
<affiliation><nlm:affiliation>Medical Research Center, Cardinal Tien Hospital and School of Medicine, College of Medicine, Fu Jen Catholic University, New Taipei City, Taiwan.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Hsueh, Shun Chung" sort="Hsueh, Shun Chung" uniqKey="Hsueh S" first="Shun-Chung" last="Hsueh">Shun-Chung Hsueh</name>
<affiliation><nlm:affiliation>Department of Medicine, College of Medicine, Taipei Medical University, Taipei, Taiwan.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Yen, Muh Yen" sort="Yen, Muh Yen" uniqKey="Yen M" first="Muh-Yen" last="Yen">Muh-Yen Yen</name>
<affiliation><nlm:affiliation>Section of Infectious Diseases, Taipei City Hospital, Taipei, Taiwan; Department of Medicine, National Yang-Ming University School of Medicine, Taipei, Taiwan.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Ko, Wen Chien" sort="Ko, Wen Chien" uniqKey="Ko W" first="Wen-Chien" last="Ko">Wen-Chien Ko</name>
<affiliation><nlm:affiliation>Department of Medicine, College of Medicine, National Cheng Kung University, Tainan, Taiwan.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Hsueh, Po Ren" sort="Hsueh, Po Ren" uniqKey="Hsueh P" first="Po-Ren" last="Hsueh">Po-Ren Hsueh</name>
<affiliation><nlm:affiliation>Department of Laboratory Medicine, National Taiwan University Hospital, National Taiwan University College of Medicine, Taipei, Taiwan; Department of Internal Medicine, National Taiwan University Hospital, National Taiwan University College of Medicine, Taipei, Taiwan. Electronic address: hsporen@ntu.edu.tw.</nlm:affiliation>
</affiliation>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">PubMed</idno>
<date when="2020">2020</date>
<idno type="RBID">pubmed:32173241</idno>
<idno type="pmid">32173241</idno>
<idno type="doi">10.1016/j.jmii.2020.02.012</idno>
<idno type="wicri:Area/PubMed/Corpus">000479</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">000479</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en">Asymptomatic carrier state, acute respiratory disease, and pneumonia due to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2): Facts and myths.</title>
<author><name sortKey="Lai, Chih Cheng" sort="Lai, Chih Cheng" uniqKey="Lai C" first="Chih-Cheng" last="Lai">Chih-Cheng Lai</name>
<affiliation><nlm:affiliation>Department of Internal Medicine, Kaohsiung Veterans General Hospital, Tainan Branch, Tainan, Taiwan.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Liu, Yen Hung" sort="Liu, Yen Hung" uniqKey="Liu Y" first="Yen Hung" last="Liu">Yen Hung Liu</name>
<affiliation><nlm:affiliation>Department of Internal Medicine, Cardinal Tien Hospital and School of Medicine, College of Medicine, Fu Jen Catholic University, New Taipei City, Taiwan.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Wang, Cheng Yi" sort="Wang, Cheng Yi" uniqKey="Wang C" first="Cheng-Yi" last="Wang">Cheng-Yi Wang</name>
<affiliation><nlm:affiliation>Department of Internal Medicine, Cardinal Tien Hospital and School of Medicine, College of Medicine, Fu Jen Catholic University, New Taipei City, Taiwan.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Wang, Ya Hui" sort="Wang, Ya Hui" uniqKey="Wang Y" first="Ya-Hui" last="Wang">Ya-Hui Wang</name>
<affiliation><nlm:affiliation>Medical Research Center, Cardinal Tien Hospital and School of Medicine, College of Medicine, Fu Jen Catholic University, New Taipei City, Taiwan.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Hsueh, Shun Chung" sort="Hsueh, Shun Chung" uniqKey="Hsueh S" first="Shun-Chung" last="Hsueh">Shun-Chung Hsueh</name>
<affiliation><nlm:affiliation>Department of Medicine, College of Medicine, Taipei Medical University, Taipei, Taiwan.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Yen, Muh Yen" sort="Yen, Muh Yen" uniqKey="Yen M" first="Muh-Yen" last="Yen">Muh-Yen Yen</name>
<affiliation><nlm:affiliation>Section of Infectious Diseases, Taipei City Hospital, Taipei, Taiwan; Department of Medicine, National Yang-Ming University School of Medicine, Taipei, Taiwan.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Ko, Wen Chien" sort="Ko, Wen Chien" uniqKey="Ko W" first="Wen-Chien" last="Ko">Wen-Chien Ko</name>
<affiliation><nlm:affiliation>Department of Medicine, College of Medicine, National Cheng Kung University, Tainan, Taiwan.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Hsueh, Po Ren" sort="Hsueh, Po Ren" uniqKey="Hsueh P" first="Po-Ren" last="Hsueh">Po-Ren Hsueh</name>
<affiliation><nlm:affiliation>Department of Laboratory Medicine, National Taiwan University Hospital, National Taiwan University College of Medicine, Taipei, Taiwan; Department of Internal Medicine, National Taiwan University Hospital, National Taiwan University College of Medicine, Taipei, Taiwan. Electronic address: hsporen@ntu.edu.tw.</nlm:affiliation>
</affiliation>
</author>
</analytic>
<series><title level="j">Journal of microbiology, immunology, and infection = Wei mian yu gan ran za zhi</title>
<idno type="eISSN">1995-9133</idno>
<imprint><date when="2020" type="published">2020</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc><textClass></textClass>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="en">Since the emergence of coronavirus disease 2019 (COVID-19) (formerly known as the 2019 novel coronavirus [2019-nCoV]) in Wuhan, China in December 2019, which is caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), more than 75,000 cases have been reported in 32 countries/regions, resulting in more than 2000 deaths worldwide. Despite the fact that most COVID-19 cases and mortalities were reported in China, the WHO has declared this outbreak as the sixth public health emergency of international concern. The COVID-19 can present as an asymptomatic carrier state, acute respiratory disease, and pneumonia. Adults represent the population with the highest infection rate; however, neonates, children, and elderly patients can also be infected by SARS-CoV-2. In addition, nosocomial infection of hospitalized patients and healthcare workers, and viral transmission from asymptomatic carriers are possible. The most common finding on chest imaging among patients with pneumonia was ground-glass opacity with bilateral involvement. Severe cases are more likely to be older patients with underlying comorbidities compared to mild cases. Indeed, age and disease severity may be correlated with the outcomes of COVID-19. To date, effective treatment is lacking; however, clinical trials investigating the efficacy of several agents, including remdesivir and chloroquine, are underway in China. Currently, effective infection control intervention is the only way to prevent the spread of SARS-CoV-2.</div>
</front>
</TEI>
<pubmed><MedlineCitation Status="Publisher" Owner="NLM"><PMID Version="1">32173241</PMID>
<DateRevised><Year>2020</Year>
<Month>03</Month>
<Day>16</Day>
</DateRevised>
<Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1995-9133</ISSN>
<JournalIssue CitedMedium="Internet"><PubDate><Year>2020</Year>
<Month>Mar</Month>
<Day>04</Day>
</PubDate>
</JournalIssue>
<Title>Journal of microbiology, immunology, and infection = Wei mian yu gan ran za zhi</Title>
<ISOAbbreviation>J Microbiol Immunol Infect</ISOAbbreviation>
</Journal>
<ArticleTitle>Asymptomatic carrier state, acute respiratory disease, and pneumonia due to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2): Facts and myths.</ArticleTitle>
<ELocationID EIdType="pii" ValidYN="Y">S1684-1182(20)30040-2</ELocationID>
<ELocationID EIdType="doi" ValidYN="Y">10.1016/j.jmii.2020.02.012</ELocationID>
<Abstract><AbstractText>Since the emergence of coronavirus disease 2019 (COVID-19) (formerly known as the 2019 novel coronavirus [2019-nCoV]) in Wuhan, China in December 2019, which is caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), more than 75,000 cases have been reported in 32 countries/regions, resulting in more than 2000 deaths worldwide. Despite the fact that most COVID-19 cases and mortalities were reported in China, the WHO has declared this outbreak as the sixth public health emergency of international concern. The COVID-19 can present as an asymptomatic carrier state, acute respiratory disease, and pneumonia. Adults represent the population with the highest infection rate; however, neonates, children, and elderly patients can also be infected by SARS-CoV-2. In addition, nosocomial infection of hospitalized patients and healthcare workers, and viral transmission from asymptomatic carriers are possible. The most common finding on chest imaging among patients with pneumonia was ground-glass opacity with bilateral involvement. Severe cases are more likely to be older patients with underlying comorbidities compared to mild cases. Indeed, age and disease severity may be correlated with the outcomes of COVID-19. To date, effective treatment is lacking; however, clinical trials investigating the efficacy of several agents, including remdesivir and chloroquine, are underway in China. Currently, effective infection control intervention is the only way to prevent the spread of SARS-CoV-2.</AbstractText>
<CopyrightInformation>Copyright © 2020. Published by Elsevier B.V.</CopyrightInformation>
</Abstract>
<AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Lai</LastName>
<ForeName>Chih-Cheng</ForeName>
<Initials>CC</Initials>
<AffiliationInfo><Affiliation>Department of Internal Medicine, Kaohsiung Veterans General Hospital, Tainan Branch, Tainan, Taiwan.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Liu</LastName>
<ForeName>Yen Hung</ForeName>
<Initials>YH</Initials>
<AffiliationInfo><Affiliation>Department of Internal Medicine, Cardinal Tien Hospital and School of Medicine, College of Medicine, Fu Jen Catholic University, New Taipei City, Taiwan.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Wang</LastName>
<ForeName>Cheng-Yi</ForeName>
<Initials>CY</Initials>
<AffiliationInfo><Affiliation>Department of Internal Medicine, Cardinal Tien Hospital and School of Medicine, College of Medicine, Fu Jen Catholic University, New Taipei City, Taiwan.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Wang</LastName>
<ForeName>Ya-Hui</ForeName>
<Initials>YH</Initials>
<AffiliationInfo><Affiliation>Medical Research Center, Cardinal Tien Hospital and School of Medicine, College of Medicine, Fu Jen Catholic University, New Taipei City, Taiwan.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Hsueh</LastName>
<ForeName>Shun-Chung</ForeName>
<Initials>SC</Initials>
<AffiliationInfo><Affiliation>Department of Medicine, College of Medicine, Taipei Medical University, Taipei, Taiwan.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Yen</LastName>
<ForeName>Muh-Yen</ForeName>
<Initials>MY</Initials>
<AffiliationInfo><Affiliation>Section of Infectious Diseases, Taipei City Hospital, Taipei, Taiwan; Department of Medicine, National Yang-Ming University School of Medicine, Taipei, Taiwan.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Ko</LastName>
<ForeName>Wen-Chien</ForeName>
<Initials>WC</Initials>
<AffiliationInfo><Affiliation>Department of Medicine, College of Medicine, National Cheng Kung University, Tainan, Taiwan.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Hsueh</LastName>
<ForeName>Po-Ren</ForeName>
<Initials>PR</Initials>
<AffiliationInfo><Affiliation>Department of Laboratory Medicine, National Taiwan University Hospital, National Taiwan University College of Medicine, Taipei, Taiwan; Department of Internal Medicine, National Taiwan University Hospital, National Taiwan University College of Medicine, Taipei, Taiwan. Electronic address: hsporen@ntu.edu.tw.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType>
<PublicationType UI="D016454">Review</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic"><Year>2020</Year>
<Month>03</Month>
<Day>04</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo><Country>England</Country>
<MedlineTA>J Microbiol Immunol Infect</MedlineTA>
<NlmUniqueID>100956211</NlmUniqueID>
<ISSNLinking>1684-1182</ISSNLinking>
</MedlineJournalInfo>
<CitationSubset>IM</CitationSubset>
<KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">2019-nCoV</Keyword>
<Keyword MajorTopicYN="N">Acute respiratory disease</Keyword>
<Keyword MajorTopicYN="N">Asymptomatic carrier</Keyword>
<Keyword MajorTopicYN="N">COVID-19</Keyword>
<Keyword MajorTopicYN="N">Coronavirus</Keyword>
<Keyword MajorTopicYN="N">SARS-CoV-2</Keyword>
<Keyword MajorTopicYN="N">Wuhan pneumonia</Keyword>
</KeywordList>
<CoiStatement>Declaration of competing interest The author declares no conflict of interests.</CoiStatement>
</MedlineCitation>
<PubmedData><History><PubMedPubDate PubStatus="received"><Year>2020</Year>
<Month>02</Month>
<Day>25</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="accepted"><Year>2020</Year>
<Month>02</Month>
<Day>25</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="entrez"><Year>2020</Year>
<Month>3</Month>
<Day>17</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="pubmed"><Year>2020</Year>
<Month>3</Month>
<Day>17</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="medline"><Year>2020</Year>
<Month>3</Month>
<Day>17</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
</History>
<PublicationStatus>aheadofprint</PublicationStatus>
<ArticleIdList><ArticleId IdType="pubmed">32173241</ArticleId>
<ArticleId IdType="pii">S1684-1182(20)30040-2</ArticleId>
<ArticleId IdType="doi">10.1016/j.jmii.2020.02.012</ArticleId>
</ArticleIdList>
</PubmedData>
</pubmed>
</record>
Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/CovidV2/Data/PubMed/Corpus
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000479 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/PubMed/Corpus/biblio.hfd -nk 000479 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien |wiki= Wicri/Sante |area= CovidV2 |flux= PubMed |étape= Corpus |type= RBID |clé= pubmed:32173241 |texte= Asymptomatic carrier state, acute respiratory disease, and pneumonia due to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2): Facts and myths. }}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Corpus/RBID.i -Sk "pubmed:32173241" \ | HfdSelect -Kh $EXPLOR_AREA/Data/PubMed/Corpus/biblio.hfd \ | NlmPubMed2Wicri -a CovidV2
![]() | This area was generated with Dilib version V0.6.33. | ![]() |